PAC-14028 Completed Phase 2 Trials for Seborrheic Dermatitis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02749383A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis